Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Methotrexate + infliximab vs Infliximab +/‐ placebo

Maintenance of clinical remission · maintenance of remission in Crohn's disease

Methotrexate + infliximab showed no clear difference in proportion of patients maintaining remission compared with infliximab +/‐ placebo (low certainty).

1 finding from 1 review

Methotrexate for maintenance of remission in Crohn's disease 2014 · Cochrane Headline outcomes only
RR 1.02 [0.76, 1.38]
2 studies · 145 participants
Low